Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C A, Bonjo"'
Autor:
Michael Millenson, Samuel Litwin, R. Kosierowski, C. McAleer, R. Alexander, Corey J. Langer, C A Bonjo, Robert F. Ozols, K. Blankstein
Publikováno v:
European journal of cancer (Oxford, England : 1990). 36(2)
In our previous study, FCCC 93-024, paclitaxel by 24-h infusion combined with carboplatin yielded a response rate of 62% and median survival of 54 weeks in advanced non-small cell lung cancer (NSCLC). Myelosuppression proved dose-limiting, requiring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4490d4b7eef5a0904675729ac89a4754
https://pubmed.ncbi.nlm.nih.gov/10741276
https://pubmed.ncbi.nlm.nih.gov/10741276
Publikováno v:
Seminars in oncology. 24(4 Suppl 12)
We previously reported a 62% response rate and 54% 1-year survival rate for paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) administered by 24-hour infusion in combination with fixed-dose carboplatin to treat patients with advanced no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fe5d0041feafb21096708b8f80c5a7b
https://pubmed.ncbi.nlm.nih.gov/9331128
https://pubmed.ncbi.nlm.nih.gov/9331128
Autor:
C J, Langer, J C, Leighton, R L, Comis, P J, O'Dwyer, C A, McAleer, C A, Bonjo, P F, Engstrom, S, Litwin, S, Johnson, R F, Ozols
Publikováno v:
Seminars in oncology. 22(4 Suppl 9)
A phase II trial of combination paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and carboplatin included 54 chemotherapy-naive patients with advanced non-small cell lung cancer. Eligibility mandated Eastern Cooperative Oncology Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93f68b8b0dae3108acaba3e1d4b46476
https://pubmed.ncbi.nlm.nih.gov/7544025
https://pubmed.ncbi.nlm.nih.gov/7544025
Publikováno v:
Lung Cancer. 18:15-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31770baae669666366f7f7d0cf7f7e54
https://doi.org/10.1016/s0169-5002(97)89328-2
https://doi.org/10.1016/s0169-5002(97)89328-2
Autor:
JC Leighton, C. McAleer, C A Bonjo, C. Luckscheiter, Corey J. Langer, A. Barsevick, D. Bruner, C. Grindel
Publikováno v:
Lung Cancer. 18:23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2d4978a849cd42244cfd1fe8346d177
https://doi.org/10.1016/s0169-5002(97)89358-0
https://doi.org/10.1016/s0169-5002(97)89358-0